BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17304340)

  • 1. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival.
    Cameron DJ; Tong Z; Yang Z; Kaminoh J; Kamiyah S; Chen H; Zeng J; Chen Y; Luo L; Zhang K
    Int J Biol Sci; 2007 Feb; 3(2):111-9. PubMed ID: 17304340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice.
    Li W; Sandhoff R; Kono M; Zerfas P; Hoffmann V; Ding BC; Proia RL; Deng CX
    Int J Biol Sci; 2007 Feb; 3(2):120-8. PubMed ID: 17311087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death.
    Vasireddy V; Uchida Y; Salem N; Kim SY; Mandal MN; Reddy GB; Bodepudi R; Alderson NL; Brown JC; Hama H; Dlugosz A; Elias PM; Holleran WM; Ayyagari R
    Hum Mol Genet; 2007 Mar; 16(5):471-82. PubMed ID: 17208947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4.
    McMahon A; Butovich IA; Mata NL; Klein M; Ritter R; Richardson J; Birch DG; Edwards AO; Kedzierski W
    Mol Vis; 2007 Feb; 13():258-72. PubMed ID: 17356513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.
    Hopiavuori BR; Deák F; Wilkerson JL; Brush RS; Rocha-Hopiavuori NA; Hopiavuori AR; Ozan KG; Sullivan MT; Wren JD; Georgescu C; Szweda L; Awasthi V; Towner R; Sherry DM; Anderson RE; Agbaga MP
    Mol Neurobiol; 2018 Feb; 55(2):1795-1813. PubMed ID: 29168048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.
    McMahon A; Butovich IA; Kedzierski W
    J Lipid Res; 2011 Jun; 52(6):1128-1138. PubMed ID: 21429867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Mutations in ELOVL4 Affect Very Long Chain Fatty Acid Biosynthesis to Cause Variable Neurological Disorders in Humans.
    Agbaga MP
    Adv Exp Med Biol; 2016; 854():129-35. PubMed ID: 26427403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
    Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
    PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
    Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.
    Okuda A; Naganuma T; Ohno Y; Abe K; Yamagata M; Igarashi Y; Kihara A
    Mol Vis; 2010 Nov; 16():2438-45. PubMed ID: 21139992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
    Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.
    Gyening YK; Chauhan NK; Tytanic M; Ea V; Brush RS; Agbaga MP
    J Lipid Res; 2023 Jan; 64(1):100317. PubMed ID: 36464075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
    Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity.
    Logan S; Agbaga MP; Chan MD; Brush RS; Anderson RE
    J Lipid Res; 2014 Apr; 55(4):698-708. PubMed ID: 24569140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function.
    Harkewicz R; Du H; Tong Z; Alkuraya H; Bedell M; Sun W; Wang X; Hsu YH; Esteve-Rudd J; Hughes G; Su Z; Zhang M; Lopes VS; Molday RS; Williams DS; Dennis EA; Zhang K
    J Biol Chem; 2012 Mar; 287(14):11469-80. PubMed ID: 22199362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELOVL4: Very long-chain fatty acids serve an eclectic role in mammalian health and function.
    Hopiavuori BR; Anderson RE; Agbaga MP
    Prog Retin Eye Res; 2019 Mar; 69():137-158. PubMed ID: 30982505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.
    Agbaga MP; Stiles MA; Brush RS; Sullivan MT; Machalinski A; Jones KL; Anderson RE; Sherry DM
    Mol Neurobiol; 2020 Nov; 57(11):4735-4753. PubMed ID: 32780351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.
    Raz-Prag D; Ayyagari R; Fariss RN; Mandal MN; Vasireddy V; Majchrzak S; Webber AL; Bush RA; Salem N; Petrukhin K; Sieving PA
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3603-11. PubMed ID: 16877435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice.
    Li W; Chen Y; Cameron DJ; Wang C; Karan G; Yang Z; Zhao Y; Pearson E; Chen H; Deng C; Howes K; Zhang K
    Vision Res; 2007 Mar; 47(5):714-22. PubMed ID: 17254625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.
    Yu M; Benham A; Logan S; Brush RS; Mandal MNA; Anderson RE; Agbaga MP
    J Lipid Res; 2012 Mar; 53(3):494-504. PubMed ID: 22158834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.